Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-146911
Filing Date
2025-06-25
Accepted
2025-06-25 16:15:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 d79970d424b3.htm 424B3 122408
2 GRAPHIC g79970g15b16.jpg GRAPHIC 57195
3 GRAPHIC g79970g88w84.jpg GRAPHIC 40025
  Complete submission text file 0001193125-25-146911.txt   254019
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-288053 | Film No.: 251073793
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)